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INTRODUCTION
Infection of rhesus monkeys with primate immunodeficiency vi-
ruses is considered to be best suited for in vivomodel studies of
HIV-1/AIDS (1). Extensive efforts to construct a novel class of
HIV-1 clones that infect rhesus macaques and induce AIDS, i.e.,
pathogenic HIV-1rmtclones, have been made to date to establish
an HIV-1 infection model system of rhesus macaques (1, 2). As
ideal input viruses for the infection studies, HIV-1rmt clones with
CCR5-tropic Env is required, since CCR5-tropic HIV-1 is strongly
associated with virus transmission between individuals, and viral
replication in an acute- infection phase (1). While some promising
proviral clones which replicate fairly well in rhesus macaques
and/or in primary rhesus peripheral blood mononuclear cells are
presently available (1, 2, and our unpublished results), no HIV-1
rmt clones pathogenic for the animals have been reported as yet.
There have been two major approaches to generate pathogenic
HIV-1rmt clones : (i) in vitro virus-construction by recombinant
DNA technology and (ii) virus adaptation in cells/individuals (3,4).
In stepwise processes of our constructing various HIV-1 clones
infectious for rhesus macaque cells, we employed (i), (ii) and/or
both strategies with the aid of computational predictive science (1, 3-
7). During virus adaptation studies using macaque cells, we consis-
tently observed that genetically engineered HIV-1 clones, ma-
caque cell - tropic but with poor replication ability in macaque cells,
readily acquired adaptive mutations in the env gene, and that the
growth-enhancing effects were not compatible between CXCR4-
tropic and CCR5-tropic viruses (5, 7). Thus, we could assume that
HIV-1 frequently adapts by Env-mutations to grow efficiently
within macaque cell environments, and that the effects of the
acquired mutations on viral growth may be specific for the HIV-1
clones.
In this study, in an attempt to improve the replication poten-
tials of our HIV-1rmt clones, we newly generated various CCR5-
tropic proviral clones, and also constructed their variants carrying N
160K, S304G, or G310R mutation in Env that were reported to have
growth-promoting effects (7, 8). These new clones were analyzed
for their single-cycle infectivity and multi -cycle replication ability.
We have demonstrated here that two proviral clones grow better
than a standard CCR5-tropic HIV-1rmt clone designated MN5/
LSDQgtu (5gtu) (1, 9, 10). We have also shown, together with our
previous results, that growth-promoting mutations in HIV-1 Env
exert their positive effects in an Env-dependent manner.
MATERIALS AND METHODS
Proviral molecular clones
Construction and characterization of a CCR5-tropic HIV-1rmt
clone designated MN5/LSDQgtu (5gtu) have been previously de-
scribed (1, 9, 10). New CCR5-tropic proviral clones were gener-
ated as outlined in Fig. 1. Mutations were introduced into the
proviral clones by the QuickChange site -directed mutagenesis kit
(Agilent Technologies Inc) as previously described (1, 11).
Nucleotide sequences
Nucleotide sequences were determined by ABI Genetic Analyzer
3130xl (Thermo Fisher Scientific).
Cells
Adherent cell lines, a human kidney 293T and a reporter cell line
TZM-bl, were cultured in Eagle’s minimal essential containing 10%
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heat- inactivated fetal bovine serum (10). A Hela-derived cell line
designated TZM-bl carries a luciferase gene in its genome driven by
the HIV-1 long terminal repeat, and is widely used for HIV/SIV
infectivity studies. M1.3S, a rhesus macaque lymphocyte cell line,
was maintained in RPMI1640 medium containing 10% heat- inac-
tivated fetal bovine serum and 50 units/ml of recombinant human
interleukin-2 (Bio-Rad Laboratories Inc) (1, 10).
Transfection
Virus stocks for infection experiments were prepared from 293T
cells transfected with various proviral clones by the calcium-
phosphate co-precipitation method (1, 12). For determination of
virus amounts, virion-associated reverse transcriptase (RT) activi-
ties were determined as previously described (1, 13).
Western blot analysis
Env proteins expressed in transfected cells and those in virions
produced from transfected cells were examined by the Western
blot technique as fully described previously (11). Virions were
partially purified and concentrated by ultracentrifugation similarly
as previously described(14, 15).
Single-cycle infectivity
Equal RT units of virus samples obtained from transfections
were inoculated into TZM-bl cells, and on day 1 post- infection,
cells were lysed with 1 x Cell Culture Lysis Reagent (Promega
Corporation) and subjected to a standard 96 well plate luciferase
assay (Promega Corporation) as instructed by the manufacturer
(10). Luciferase activity in the cell lysates relative to that of 5gtu was
determined, and considered as viral single-cycle infectivity.
Multi-cycle replication ability
Equal RT units of virus samples obtained from transfections
were inoculated into M1.3S cells, and virus growth kinetics were
determined by monitoring RT activity in the culture supernatants
every 3 days as previously described (1, 10).
RESULTS
Generation of new HIV-1rmt clones
To our knowledge, pMN4/LSDQgtu is currently the best HIV-1
molecular clone to generate infectious viruses that replicate
efficiently in rhesus macaque cells (1, 16). MN4/LSDQgtu is
CXCR4-tropic and exhibits resistance to major intrinsic HIV-1 re-
striction factors in macaque cells, such as APOBEC3 proteins,
TRIM5 proteins, and tetherin. In fact, the CXCR4-tropic virus de-
rived from this molecular clone constantly grew to a considerable
level in rhesus macaques (our unpublished data). However, any
AIDS-related symptoms in rhesus macaques infected with MN4/
LSDQgtu were not observed so far (our unpublished data). In addi-
tion, CCR5-tropic viruses are required to mimic well the disease
progression in individuals (1). We, therefore, started generating a
number of new CCR5-tropic HIV-1rmt clones to increase varie-
ties of input viruses for rhesus experiments. In order to obtain new
HIV-1rmt proviral clones, we used in vitro (DNAs) and in vivo
(cells) methods as illustrated in Fig. 1. Briefly, env gene regions
derived from a molecular clone (pSHIVAD8 - EH) of a pathogenic virus
(17) and from two clinical isolates (CI) were inserted into 5gtu
backbone by both standard DNA recombinant and intracellular
homologous recombination (18) techniques. As a result, we suc-
cessfully constructed five new clones designated gtu+AD8, gtu+
CI1, gtu+A4CI1, gtu+CI3, and gtu+B3AD8 that produce infectious
viruses upon transfection (Fig. 1). Clones gtu+AD8/gtu+B3AD8
and gtu+CI1/gtu+A4CI1/gtu+CI3 carry the env gene region de-
rived from pSHIVAD8 - EH and from one of the two clinical isolates,
respectively.
Because gtu+AD8 and gtu+B3AD8 have the env gene region
from pSHIVAD8 - EH, and the gtu+B3AD8 was generated by the intra-
cellular recombination method, we were interested in potential se-
quence differences in the two clones. By the same reason, env gene
regions of gtu+CI1 and gtu+A4CI1 were compared, and consider-
able sequence differences were noted (the sequences will be de-
scribed elsewhere) (Table 1). Fig. 2 shows the sequence align-
ment of 5gtu, gtu+AD8, and gtu+B3AD8. Importantly, we found a
19-nucleotide deletion only in gtu+B3AD8 vpu (Fig. 2A and Table
1), which is very likely to inactivate the Vpu activity in cells by
abolishing its expression or by expressing a defective protein. We
also found 7 amino acid differences between Env proteins of gtu+
AD8 and gtu+B3AD8 (Fig. 2B and Table 1). Finally, as expected,
there were some amino acid differences among 5gtu, gtu+AD8,
and gtu+B3AD8 (Fig. 2B). Parental clone 5gtu has the growth-
enhancingN160K and S304G residues but not gtu+AD8 and gtu+
B3AD8(Table1).
Virological characterization of HIV-1rmt clones
We then confirmed the Env expression of the five new CCR5-
tropic clones in transfected 293T cells by Western blot analysis.
HIV-1 Env is expressed in cells as a precursor gp160, which is
composed of gp120 and gp41. Gp160 is cleaved at the final virus
replication step (assembly/budding/maturation) to generate mature
products gp120 (surface) and gp41 (transmembrane). Env-gp120
and Env-gp41 incorporated into virions subsequently work for the
receptor/co-receptor binding and the virus/cell fusion in the next
round of the infection cycle, respectively. As shown in Fig. 3, al-
though heterogeneities were observed between clones in terms of
the proteins size and amount, the five clones did express Env pro-
teins both in cells and virions. While clones gtu+CI1 and gtu+A4CI1
gave a relatively uniform Env in virions, clones gtu+AD8 and gtu+
B3AD8 particularly produced heterogeneous Env proteins at a
relatively higher level.
We next comparatively determined replication potentials of the
new clones relative to that of 5gtu. As shown in Fig. 4A, viral single-
cycle infectivity in reporter TZM-bl cells was assessed for gtu+AD8,
gtu+B3AD8, gtu+CI1, gtu+A4CI1, and gtu+CI3 (Fig. 1). All clones
tested were found to exhibit significantly lower infectivity than
that of 5gtu. However, of note, gtu+AD8 showed higher infectivity
than gtu+B3AD8 (P0.005). We asked whether the amino acid
substitutions, N160K and S304G (Fig. 2) that were reported to
enhance viral infectivity (7, 8), improve replication potentials of the
above five clones. Clones gtu+CI1 and gtu+A4CI1 natively have
the G304 residue (Table 1). As shown in Figure 4B and 4C, no
significant augmentation of viral infectivity by the mutations was
observed.
Finally, we determined viral growth kinetics in macaque M1.3S
cells of the five clones in Fig. 4A in comparison with 5gtu to see if
there is any difference between results on single-cycle and multi -
cycle infectivities. Notably, as shown in Fig. 5, gtu+CI1 and gtu+
A4CI1 grew better than 5gtu as well as the other three clones (gtu+
AD8, gtu+B3AD8, and gtu+CI3), in contrast to the results on
single-cycle infectivity (Fig. 4A). The three clones (gtu+AD8,
gtu+B3AD8, and gtu+CI3) grew more poorly than 5gtu in agree-
ment with the single-cycle infectivity data (Fig. 4A). There are two
modes of virus spreading infection, cell - free infection and cell - to -
cell infection. The former is the process that infectious virions re-
leased into culture supernatants from cells are transmitted to unin-
fected cells. The latter is the mode that viruses spread via cell to cell
interaction without infectious virions release. Therefore, even if
infection efficiency of initial input virus is quite low, the virus with a
higher capability of cell - to -cell infection may exhibit an enhanced
growth ability in the multi -cycle replication analysis. The remark-
able results on gtu+CI1 and gtu+A4CI1 could be explained by their
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Figure 1 Generation of new full - length proviral clones. Using pMN5/LSDQgtu (5gtu) (1, 9, 10), pSHIVAD8 - EH (17), and two env clones from clinical
isolates (CI) (unpublished), five proviral clones designated gtu+AD8, gtu+B3AD8, gtu+CI1, gtu+A4CI1, and gtu+CI3 were generated as
detailed in this figure. See reference 18 for the intracellular homologous recombination used to generate gtu+B3AD8 and gtu+A4CI1.
Locations of Gag-capsid (CA) mutations (1) and adaptive mutations in Pol (two mutations)/Env-S304G (7) are represented by arrows and dotted
arrows, respectively. Regions derived from SIVmac239 (simian immunodeficiency virus clone 239 isolated from a rhesus macaque) and SIVgsn166 (SIV
clone 166 from a greater spot -nosed monkey) are indicated by black and light purple, respectively.
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accelerated cell - to -cell spread ability mediated by their Env pro-
teins. Efficient cell - to -cell infection may have advantages in virus
spread in vivo, because this mode of infection is in favor of evasion
from host immune system. Apparent differences in single-/multi -
cycle infectivity observed among gtu+AD8, gtu+B3AD8, and gtu+
CI3 (compare the results in Fig. 4A and Fig. 5) may also be explain-
able with their different cell - to -cell spread abilities. We further
examined the effect of G310R mutation in Env (Fig. 2) on the
growth kinetics of gtu+AD8, gtu+B3AD8, gtu+CI1, gtu+A4CI1,
and gtu+CI3 (Fig. 1). We recently showed that a mutant virus
carrying a growth-enhancing mutation G310R exhibited distinct
sensitivity to CCR5 antagonist TAK-779 from that of a mutant virus
bearing S304G (19). Fig. 6 shows the results for gtu+B3AD8/gtu+
CI3 and their mutant viruses as representatives. Neither of the mu-
tants grew better than parental viruses like the other three mu-
tants.
DISCUSSION
In this study, in order to increase viral replication potential and
variation for infections of rhesus macaques, we generated five new
CCR5-tropic proviral clones (gtu+AD8, gtu+B3AD8, gtu+CI1,
gtu+A4CI1, and gtu+CI3), and also mutant clones derived from
them. From these, we successfully identified two proviral clones
(gtu+CI1 and gtu+A4CI1) that grow better in macaque M1.3S
cells than 5gtu, the best CCR5-tropic HIV-1rmt currently available
(1, 9, 10). Proviral clones designated gtu+CI1 and gtu+A4CI1
showed high replication potentials relative to that of the standard
clone 5gtu (Fig. 5) despite their low single-cycle infectivity rela-
tive to that of 5gtu (Fig. 4A). The unique and neat Env expression
pattern observed for the two clones (Fig. 3) is noteworthy. Env-gp
120 proteins of gtu+CI1 and gtu+A4CI1 may be proper for highly
infectious virions. Biological and molecular bases for high replica-
tion potentials of gtu+CI1 and gtu+A4CI1 clones need to be clari-
fied. In contrast, gtu+CI3 display a relatively low level of Env-gp
120 content in the virion, and this may be responsible for the
lower replication ability compared to that of the other R5-tropic
HIV-1rmt clones. But, for now, we cannot exclude the possibility
that the observation by the immunoblotting is due to the antibody
affinity to each Env protein of HIV-1rmt clones. On the other hand,
the number of HIV-1 Env trimers incorporated into virions is unex-
pectedly small, and suitable numbers are different for the produc-
tion of infectious virions among HIV-1 strains (20). A relatively
Figure 2 Sequence alignment of 5gtu, gtu+AD8, and gtu+B3AD8. (A) Nucleotide sequences of the vpu-env overlapping region. Dots and hyphens
indicate identical nucleotides and nucleotide gaps, respectively. (B) Amino acid sequences of Env-signal peptide, Env-gp120, and Env-gp41.
Dots and hyphens show identical amino acids and amino acid gaps, respectively. Env-gp120 domains (C1 to V5) are indicated above the sequences.
Arrows represent different amino acids in Env proteins of gtu+AD8 and gtu+B3AD8. Sites for introduction of N160K, S304G, and G310R
mutations are indicated (see text).
Table1 Summary of HIV-1rmt Env proteins in this study
HIV-1rmt clones Virus origin of
CCR5-tropic
Env proteins
Number of
amino acids in
Env proteins
Comparison of amino
acid sequences of Env
proteins*
Amino acids at the sites of
growth-promoting mutations
Comments
Identity Similarity 160 304 310
MN5/LSDQgtu HIV-1SF162 847 K G G
gtu+AD8 SHIVAD8 - EH 850 87% 97% N S G A 19-nucleotides deletion in
the vpu gene of gtu+B3AD8
relative to that of gtu+AD8 is
found. Seven amino acid dif-
ferences are present in the
two Env proteins.
gtu+B3AD8 850 86% 97% N S G
gtu+CI1 Clinical isolate 876 77% 93% N G G Seven amino acid differences
are noted in the Tat/Rev/
Env/Nef proteins of the two
clones.
gtu+A4CI1 876 77% 93% N G G
gtu+CI3 Clinical isolate 869 71% 91% N S G
*Identity and similarity for Envamino acids relative to those of MN5/LSDQgtu as analyzed by Genetics version 11 are shown.
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high expression levels of Env observed for gtu+AD8 and gtu+B3
AD8 can adversely affect the production of infectious virions and
the subsequent replication process.
One of important points in the present study is regarding the
receptive ability of HIV-1 Env proteins in amino acid substitutions
for high functional activity. The N160K substitution was shown to
influence viral infectivity positively (8) or negatively (20), which
depends on the clones used.We previously reported that the S304G
substitution enhances specifically the growth ability of CCR5-tropic
NL-DT562 but not that of CXCR4-tropicNL-DT5R (7). Our re-
sults in this study are consistent with these results with respect to
the Env-dependency. The G310R mutation, another growth-en-
hancing adaptive mutation found to occur in NL-DT562 genome
(7), impeded or abolished viral single-cycle infectivity of CCR5-
tropic clones other thanNL-DT562 (Fig. 6). In conclusion, we
demonstrate here that the enhancing effects of Env mutations are
applicable to some specific Env. Care must be taken if we are to
generate better growing HIV-1rmt clones by Env-mutations.
Our goal would be the establishment of HIV-1rmt clone(s)
that replicates well to a level sufficient enough for diversification
of viruses to persist and cause AIDS/AIDS-related complex in
Figure 3 Western blot analysis of Env proteins in virions and cells. Proviral clones indicated were transfected into 293T cells, and on day 2 post -
transfection, virion and cell lysates were prepared for Western blotting using anti -Env (#ADP409) and anti -Gag-p24 (#3537) antibodies. For
detection, lysates containing 10 ng of p24 (Virion Env), 2 ng of p24 (Virion p24), and 1 ng of p24 (Cell Env and Cell p24) were used. NC,
negative control (mock- transfected).
Figure 4 Single -cycle infectivity of new proviral clones. Virus samples
were prepared from transfected 293T cells, and equal RT units (2 x 104
or 1 x 105) were inoculated into TZM-bl cells (5 x 103) for luciferase
assays. Results are separately shown for new proviral clones (A) and their
mutant clones (B and C). Luciferase activity relative to that by 5gtu is
shown. Mean valuesSD from at least three independent experi-
ments for each panel are shown. Significance relative to 5gtu was deter-
mined by the Student’s t - test (for all samples, P0.005). Clone names are
indicated at the bottom. NK, N160K ; SG, S304G.
Figure 5 Growth kinetics of new viral clones in M1.3S cells. Viruses
were prepared from 293T cells transfected with indicated proviral clones,
and equal RT units (5 x 105) were inoculated into M1.3S cells (2 x 105). RT
activity in the culture supernatants was determined every 3 days post -
infection as shown. The experiment was repeated three times with consis-
tent results.
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infected rhesus macaques. We have previously experienced that vi-
ruses with low replication potentials in macaque cells can fre-
quently mutate to highly replicative viruses during numerous
infection cycles in macaque cells (1, 3 -7). This empirical “cell -
adaptation” method is a powerful tool to generate virus variants
with high replication potentials under some conditions. Indeed,
based on the clones described here, we have now obtained some
proviral clones by cell -adaptation promising for future use. Studies
in this direction are in progress in our laboratory.
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